RFA-EB-23-005: Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2023.
National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on January 22, 2025.
From the official notice on Grants.gov, last changed January 11, 2024. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeR21
- Clinical trialsOptional
- Funded byNIBIB
- Median yearly award$377,809
- Typical project length2 years
- R21, Exploratory/Developmental Research Grant. Early, exploratory ideas that may not have preliminary data yet, usually for up to two years. Other open R21 notices.
Projects funded under RFA-EB-23-005 were run by National Institute of Biomedical Imaging and Bioengineering (NIBIB, 6 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-EB-23-005 in the NIH Guide.
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| RFA-EB-23-001 | February 1, 2023 | Closed April 28, 2023 | Closed |
Key dates
| Posted | April 28, 2023 |
|---|---|
| Deadline | January 22, 2025 |
| Archived by Grants.gov | February 21, 2025 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Is this a realistic fit?
- Most of the program's money (76% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
Ethical considerations are intrinsic to the conduct of robotic and bionic device research. This Notice of Funding Opportunity (NOFO) invites applications that propose research on ethical questions associated with all stages of the design, testing, and/or implementation of bionic and robotic devices.
Funded under RFA-EB-23-005 so far
NIH funded 6 projects under RFA-EB-23-005 in fiscal 2024 to 2026, at 6 institutions. The median yearly award was $377,809.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Anticipating bioethical issues in enhancement prosthetics | University of Virginia | 2026 | $454,810 |
| Bionic and robotic prostheses: identifying bioethical concerns from key groups to improve development and clinical translation approaches | University of North Texas HLTH Sci Ctr | 2025 | $6 |
| Giving and Taking Away: Mapping Ethical Recommendations for Addressing Emotional Retraumatization in Bionics Research | Cleveland Clinic Lerner Com-Cwru | 2025 | $398,466 |
| Fostering Ethical Adoption of Artificial Intelligence-Enabled Assistive Robots (AIAR) Grounded in Person-Centered Dementia Care | University of New Hampshire | 2025 | $214,833 |
| Ethical Considerations in The Design and Testing of Back-Support Exoskeletons | Clemson University | 2024 | $377,809 |
| Ethical Approaches to Informed Consent for Autonomous Robotic Assisted Surgery | Vanderbilt University | 2024 | $453,143 |
Who has won Discovery and Applied Research for Technological Innovations to Improve Human Health grants before
From fiscal 2021 to 2025, Discovery and Applied Research for Technological Innovations to Improve Human Health (93.286) awarded $1.8 billion across 1,983 grant awards, an average of $886,380 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The General Hospital Corporation | Massachusetts | 75 | $83.5 million |
| The Johns Hopkins University | Maryland | 68 | $83.5 million |
| The Leland Stanford Junior University | California | 64 | $53.0 million |
| Brigham & Womens Hospital Inc | Massachusetts | 41 | $49.5 million |
| The Trustees of the University of Pennsylvania | Pennsylvania | 44 | $48.3 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-EB-23-005 still open?
No. It closed on January 22, 2025.
Who can apply for Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)?
Closed January 22, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under RFA-EB-23-005?
NIH RePORTER lists 6 projects funded under RFA-EB-23-005 in fiscal 2024 to 2026, at 6 institutions. The most were at University of Virginia, University of North Texas HLTH Sci Ctr, Cleveland Clinic Lerner Com-Cwru.
Who has won Discovery and Applied Research for Technological Innovations to Improve Human Health grants before?
The largest recipients over five fiscal years were The General Hospital Corporation, The Johns Hopkins University, The Leland Stanford Junior University. The program made 1,983 awards worth $1.8 billion in that time.
Similar open grants
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
- Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)